# US 2006/0052947 A1 · Biofabrication of transistors including field effect transistors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0052947 A1
- Document ID: US20060052947A1
- Status: Published application
- Kind: A1
- Application number: 11/130,399
- Filed: 2005-05-17
- Published: 2006-03-09
- Earliest claimed: 2004-05-17
- Inventors: Evelyn Hu
- Web page: https://patentgrep.com/patent/US20060052947A1

## CPC

- H10D 64/01336: {on single crystalline silicon, e.g. chemical oxidation using a liquid}
- B82Y 10/00: Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
- G01N 33/54373: {involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings}
- G11C 13/0014: {comprising cells based on organic memory material}
- G11C 13/0019: {comprising bio-molecules}
- H10D 30/027: {of lateral single-gate IGFETs}
- H10D 30/031: {of thin-film transistors [TFT]}
- H10D 62/118: {Nanostructure semiconductor bodies}
- H10D 62/121: {oriented parallel to substrates}
- H10D 64/01316: {the conductor comprising a layer of elemental metal contacting the insulator, e.g. Ta, W, Mo or Al}
- H10D 64/691: {comprising metallic compounds, e.g. metal oxides or metal silicates (insulators comprising nitrogen H10D64/693)}
- H10D 30/024: {of fin field-effect transistors [FinFET]}
- H10D 30/62: Fin field-effect transistors [FinFET]
- H10D: INORGANIC ELECTRIC SEMICONDUCTOR DEVICES
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G11C: STATIC STORES (semiconductor memory devices H10B)

## Abstract

Use of peptides and other biological agents for fabrication of transistors, field effect transistors, and components thereof. An intermediate component for use in fabrication of a field effect transistor, the component comprising at least two of the following transistor elements: (i) source, (ii) drain, (iii) channel, (iv) gate, and (v) dielectric, wherein the at least two elements are combined by a biological agent comprising at least two binding structures, wherein each of the binding structures is bound to one of the at least two elements. The channel can be a nanowire or a nanotube which is surrounded by a high-K dielectric material, which is further surrounded by a metal gate layer. The biological agent can be a bifunctional peptide which binds dielectric to channel or binds dielectric to gate materials.

## Claims

### Claim at position 1

1-105. (canceled)

### Claim 106

An component for use in fabrication of a transistor, the component comprising at least two of the following transistor elements: (i) source, (ii) drain, (iii) channel, (iv) gate, and (v) dielectric, wherein the at least two elements are combined by a biological agent comprising at least two binding structures, wherein each of the binding structures is bound to one of the at least two elements.

### Claim 107 (depends on 106)

The component according to claim 106, wherein the transistor is a field effect transistor.

### Claim 108 (depends on 107)

The component according to claim 107, wherein the field effect transistor is a MISFET, a MOSFET, a MESFET, or a JFET.

### Claim 109 (depends on 106)

The component according to claim 106, wherein the biological agent is a synthetic or engineered peptide.

### Claim 110 (depends on 106)

The component of claim 106, wherein the channel comprises a nanowire or nanotube.

### Claim 111 (depends on 110)

The component of claim 110, wherein the nanowire comprises a compositionally modulated material.

### Claim 112 (depends on 106)

The component of claim 106, wherein the channel comprises an electrically conductive polymer.

### Claim 113 (depends on 106)

The component of claim 106, wherein the gate is part of a wrap around gate structure.

### Claim 114 (depends on 106)

The component of claim 106, wherein the gate is a metallic gate.

### Claim 115 (depends on 106)

The component of claim 106, wherein the gate is a semiconductor gate.

### Claim 116 (depends on 106)

The component of claim 106, wherein the dielectric is a high K dielectric.

### Claim 117 (depends on 106)

The component of claim 106, wherein the dielectric is an oxide.

### Claim 118 (depends on 106)

The component according to claim 106, wherein the source, channel, and drain are present as an integrated structure, and the biological agent comprising at least two binding structures further binds the source and drain to additional source and drain structures.

### Claim 119

An electronic device comprising a plurality of field effect transistors, wherein the field effect transistors comprise channels comprising nanowires which are substantially monodisperse in length.

### Claim 120

A nanowire structure comprising a nanowire core and a first nanowire outer layer surrounding the core, wherein a biological agent comprising at least two binding structures is used to combine the nanowire core and the nanowire outer layer.

### Claim 121 (depends on 120)

The nanowire structure according to claim 120, further comprising a second nanowire outer layer which surrounds the first outer layer.

### Claim 122 (depends on 120)

The nanowire structure of claim 120, wherein the core nanowire is a heterostructure and comprises end materials.

### Claim 123

An intermediate component for use in fabrication of a transistor, the component comprising at least two of the following transistor elements: (i) source, (ii) drain, (iii) channel, (iv) gate, and (v) dielectric, wherein the at least two elements are combined by a biological agent comprising at least two binding structures, wherein each of the binding structures is bound to one of the at least two elements.

### Claim 124 (depends on 123)

The intermediate component according to claim 123, wherein the transistor is a field effect transistor comprising a wrap around gate.

### Claim 125

A process for fabricating elements of a field effect transistor, comprising the step of combining at least a channel element and a source or drain element, wherein at least one biological agent comprising at least two binding structures is used to combine the channel element and the source or drain element.

### Claim 126

A method for engineering the surface of a nanowire with an outer layer material comprising the step of binding the surface of the nanowire with a biological agent comprising at least two binding structures, one binding structure for the surface of the nanowire, and one binding structure for the outer layer material.

### Claim 127 (depends on 126)

The method of claim 126, wherein the nanowire is formed using biological agents.

### Claim 128 (depends on 126)

The method of claim 126, wherein a material is deposited on the surface of the outer layer material.

### Claim 129

A biological agent represented by A-B-C, wherein A and C are selective binding structures and B is an optional linking structure, wherein A and C selectively bind to a channel, a dielectric, a gate, a source, or a drain material.

### Claim 130

A field effect transistor comprising a nanowire or nanotube channel, a dielectric material surrounding the channel, and a metal or semiconductor layer surrounding the dielectric material.

### Claim 131 (depends on 130)

The transistor according to claim 130, wherein the dielectric material or metal layer surrounding the dielectric material are deposited using biological agents.

### Claim 132 (depends on 130)

The field effect transistor according to claim 130, wherein the nanowire or nanotube forms an integrated structure with source and drain structures.

### Claim 133

A method of forming a field effect transistor comprising
providing a nanowire or nanotube channel,
depositing a dielectric material to surround the channel, and
depositing a metal layer or semiconductor layer to surround the dielectric material, wherein at least one of the deposition steps is performed using a biological agent.

### Claim 134

A transistor comprising a nanowire or nanotube channel, a dielectric material surround the channel and having a K value of about 10 or more, and a gate layer surrounding the dielectric material.

### Claim 135

A method of forming a dielectric layer surrounding a nanowire or a nanotube comprising the steps of providing the nanowire or nanotube, providing the dielectric material or a precursor thereof, providing a biological agent which comprises at least two binding structures, and forming the dielectric layer on the nanowire or nanotube in the presence of the biological agent.

### Claim 136

A method of forming a gate layer surrounding a dielectric material comprising the steps of providing the dielectric material, providing the gate material or a precursor thereof, providing a biological agent which comprises at least two binding structures, and forming the gate layer on the dielectric material in the presence of the biological agent.

### Claim 137

A method of forming a connection between a nanowire or a nanotube and a source or a drain, comprising the steps of providing a biological agent which comprises at least two binding structures, providing the nanowire or the nanotube, providing the source or drain, and connecting the nanowire or nanotube with the source or drain in the presence of the biological agent.

### Claim 138

A method of forming a metal layer surrounding a nanowire or a nanotube comprising the steps of providing the nanowire or nanotube, providing the metal material or a precursor thereof, providing a biological agent which comprises at least two binding structures, and forming the metal layer on the nanowire or nanotube in the presence of the biological agent.

### Claim 139

A method of forming a semiconductor layer surrounding a nanowire or a nanotube comprising the steps of providing the nanowire or nanotube, providing the semiconductor material or a precursor thereof, providing a biological agent which comprises at least two binding structures, and forming the semiconductor layer on the nanowire or nanotube in the presence of the biological agent.
